Atlanta, Georgia – The Centers for Disease Control and Prevention issued a warning to the public about the consumption of Diamond Shruumz chocolates, cones, and gummies due to an outbreak of severe illnesses that has resulted in 10 hospitalizations. Following reports of a dozen individuals falling ill in eight states after ingesting the brand’s “microdosing” mushroom edibles, the CDC has advised health care providers to be cautious.
Symptoms of those affected included seizures, sedation, muscle stiffness, abdominal pain, abnormal heart rate, and fluctuations in blood pressure. While no fatalities were reported, many patients required ventilator support and admission to intensive care units. The true scale of the outbreak may be larger than reported, with poison control centers across the nation receiving numerous reports of illnesses linked to Diamond Shruumz products.
According to experts, Diamond Shruumz products are marketed as intended for microdosing, which typically involves consuming small amounts of psychoactive substances to minimize adverse effects. However, despite the company claiming that its products do not contain psychedelic substances, toxicology experts have raised concerns about the ingredients listed, stating that they do not produce the advertised effects of relaxation or euphoria.
The CDC highlighted the increasing availability of products containing psychoactive ingredients, such as mushroom extracts, which are often disguised as gummy candies or chocolates. These products may contain undisclosed or harmful contaminants not approved for consumption. Despite requests for comment, Diamond Shruumz has remained silent on the matter.
The lack of regulatory oversight in the dietary supplement industry has raised concerns about the quality control of products like Diamond Shruumz. Experts warn that undisclosed ingredients or illegal substances may be present in these products, leading to harmful effects on consumers. In light of these risks, the FDA has urged the public to avoid consuming any Diamond Shruumz products and to discard any that may be in their possession.
As investigations into the cause of the illnesses continue, health officials emphasize the importance of transparency and adherence to regulatory standards to protect consumers from potentially harmful products. The FDA has pledged to monitor the marketplace for any unlawful products and take action to safeguard public health.